Trial Details
Not RecruitingBasic Information
| Clinical ID | c3147 |
|---|---|
| Identifier | EUCTR2013-001503-37-DK |
| Trial Title | Effect of low-dose Azathioprine and Allopurinol compared to Azathioprine on clinical outcomes in Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory Bowel Disease, (Ulcerativ colitis, Crohns disease) MedDRA version: 14.1_Level: PT_Classification code 10021972_Term: Inflammatory bowel disease_System Organ Class: 10017947 - Gastrointestinal disorders_;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Trade Name: Imurel Pharmaceutical Form: Tablet INN or Proposed INN: azathioprine CAS Number: 446-86-6 Other descriptive name: AZATHIOPRINE Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 50- Trade Name: Allopurinol Pharmaceutical Form: Tablet INN or Proposed INN: allopurinol CAS Number: 17795-21-0 Other descriptive name: ALLOPURINOL SODIUM Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 100- |
Participant Information
| Sponsor | Marianne Kiszka-Kanowitz |
|---|---|
| City | - |
| Country/Region | Denmark |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |